Tumiclas, Alin .
HRN: 12-33-36 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/01/2024
MUPIROCIN 2%, 15G (TUBE)
09/01/2024
09/07/2024
TOPICAL
12%, 15g
BID
S/P Cesarean Section
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes